Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Aarhus University Hospital | OTHER |
| Danish Cancer Society | OTHER |
| Vejle Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
The goal of this observational study is to learn why some patients develop low anterior resection syndrome (LARS) after colorectal cancer treatment. The study also aims to identify different subtypes of LARS and understand which patients may respond to specific treatments.
The main questions it aims to answer are:
Participants will:
Complete advanced physiological and imaging assessments related to bowel function
Be compared with four control groups:
Take part in a single study visit where all measurements are performed
Low anterior resection syndrome (LARS) is a common long-term complication after colorectal cancer surgery. Up to 80% of patients experience symptoms such as urgency, frequent bowel movements, clustering, and fecal incontinence. These symptoms can severely affect quality of life, and the underlying causes are not fully understood. LARS appears to result from several interacting mechanisms, including sensory changes, altered motility, reduced reservoir function, sphincter dysfunction, and effects of chemotherapy or radiotherapy. Because different patients may have different dominant mechanisms, treatment responses vary widely.
This observational study aims to investigate the physiological and imaging characteristics of LARS using advanced assessment methods. The goal is to better understand the mechanisms behind LARS, identify distinct patient subtypes, and support development of more targeted treatment strategies.
The study will include 50 patients with minor or major LARS after rectal cancer surgery. Their results will be compared with four control groups:
All participants will attend a single study visit that includes advanced physiological measurements, Magnetic Resonance Imaging (MRI)-based assessments, and standardized questionnaires. These methods are not part of routine clinical care but are used to explore mechanisms such as motility, sensory function, sphincter activity, and rectal reservoir function.
Patients with LARS will also be followed during their standard stepwise treatment pathway. They will complete questionnaires before and during each treatment step, which may include dietary advice, medication, pelvic floor training (biofeedback), and rectal emptying techniques such as mini-enemas or transanal irrigation. This follow-up will help determine how different physiological patterns relate to treatment response.
The study is conducted in collaboration between Aarhus University Hospital and Aalborg University Hospital, with expert input from The Royal London Hospital (UK) and Motilis SA (Switzerland).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| LARS, minor or major symptoms | LARS score ≥ 20; Patients operated for rectal cancer with a rectal resection and sphincter preserving surgery at a minimum of three months postoperative. If patients have received a temporary protective ileostomy, this should have been reversed for a minimum of three months postoperative. | ||
| LARS, no symptoms | LARS score < 20; Patients operated for rectal cancer with a rectal resection and sphincter preserving surgery at a minimum of three months postoperative. If patients have received a temporary protective ileostomy, this should have been reversed for a minimum of three months postoperative. | ||
| Faecal Incontinence |
| ||
| Faecal Incontinence, urge |
| ||
| Watch and wait | Rectum/colon cancer patients treated with organ-preserving treatment, i.e., chemotherapy and radiotherapy with a complete clinical and radiological response at a minimum of 12 months posttreatment |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| EuroQol 5-Dimension, 5-Level quality-of-life questionnaire | The EuroQol 5-Dimension, 5-Level questionnaire assesses generic health-related quality of life across five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each domain has five response levels ranging from "no problems" to "extreme problems." Score range and direction: Higher scores indicate better health-related quality of life. Includes a visual analogue scale (0-100) where higher scores indicate better self-rated health. | From baseline visit to the end of each standardized treatments at 4 weeks |
| Low Anterior Resection Syndrome Score | The Low Anterior Resection Syndrome (LARS) Score is a disease-specific symptom questionnaire assessing bowel dysfunction after low anterior resection. It includes five items covering incontinence, frequency, clustering, urgency, and impact on daily life. Score range and direction: Total score ranges from 0 to 42. Higher scores indicate more severe bowel dysfunction. Severity categories: 0-20: No LARS 21-29: Minor LARS 30-42: Major LARS | From baseline visit to the end of each standardized treatments at 4 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| St Mark's Incontinence score | Description: The St. Mark's Incontinence Score assesses the severity of fecal incontinence across multiple domains, including incontinence to gas, liquid, and solid stool, urgency, use of pads, and lifestyle impact. Score range and direction: Total score ranges from 0 to 24. Higher scores indicate more severe fecal incontinence. | • Applied at baseline and four weeks into all treatment periods |
Not provided
Inclusion Criteria:
General:
Specific inclusion criteria for LARS patients:
Specific inclusion criteria for fecal incontinence patients and urge fecal incontinence patients
Specific inclusion criteria for "watch and wait" patients:
• Rectum/colon cancer patients treated with organ-preserving treatment, i.e., chemotherapy and radiotherapy with a complete clinical and radiological response at a minimum of 12 months posttreatment.
Exclusion Criteria:
General exclusion criteria
Specific exclusion criterias for LARS patients
Not provided
Not provided
Not provided
During outpatient visits, the treatment responsible doctor will identify eligible patients. Patients will be recruited at the following departments:
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Esben B Mark, PhD | Contact | 97663523 | +45 | e.mark@rn.dk |
| Name | Affiliation | Role |
|---|---|---|
| Peter Christensen, MD, Professor | Pelvic Floor Unit, Department of Surgery, Aarhus University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aalborg University Hospital | Active, not recruiting | Aalborg | 9220 | Denmark | ||
| Aarhus University Hospital |
Individual participant data will not be shared because the study involves sensitive health information and data protection regulations (GDPR) prevent public sharing of identifiable or de-identified participant-level data.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000094123 | Low Anterior Resection Syndrome |
| D004688 | Encopresis |
| ID | Term |
|---|---|
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Colostomy Impact Score | The Colostomy Impact Score is a disease-specific questionnaire evaluating the impact of living with a colostomy on daily functioning, social participation, body image, and emotional well-being. Score range and direction: Total score ranges from 0 to 100. Higher scores indicate greater negative impact of the colostomy on quality of life. | From baseline visit to the end of each standardized treatments at 4 weeks |
| Bristol Stool Form Scale | The Bristol Stool Form Scale classifies stool consistency into seven categories ranging from hard, lumpy stools to entirely liquid stools. It is used as an indicator of bowel transit and stool form. Score range and direction: Scale ranges from Type 1 to Type 7. Lower types (1-2) indicate harder stools and slower transit. Middle types (3-4) indicate normal stool form. Higher types (6-7) indicate loose or watery stools and faster transit. | From baseline visit to the end of each standardized treatments at 4 weeks |
| Patient Assessment of Constipation Symptoms (PAC-SYM) | The Patient Assessment of Constipation Symptoms questionnaire measures symptom severity in constipation across three domains: abdominal symptoms, stool symptoms, and rectal symptoms. Score range and direction: Each item is scored 0-4; total score ranges from 0 to 48. Higher scores indicate more severe constipation symptoms. | From baseline visit to the end of each standardized treatments at 4 weeks |
| Wexner Incontinence Score | The Wexner Incontinence Score evaluates the severity of fecal incontinence based on frequency of incontinence to gas, liquid, and solid stool, need for pads, and lifestyle alteration. Score range and direction: Total score ranges from 0 to 20. Higher scores indicate more severe fecal incontinence. | From baseline visit to the end of each standardized treatments at 4 weeks |
| Hospital Anxiety and Depression Scale (HADS) | The Hospital Anxiety and Depression Scale assesses symptoms of anxiety and depression in medical populations. It consists of two subscales: HADS-Anxiety and HADS-Depression. Score range and direction: Each subscale ranges from 0 to 21. Higher scores indicate more severe symptoms of anxiety or depression. Total score (0-42) may be reported but is less commonly used. | From baseline visit to the end of each standardized treatments at 4 weeks |
| Whole gut and segmental transit times as measured with 3D-Transit | Whole-gut and segmental gastrointestinal transit times are measured using the Motilis 3D-Transit system. The system tracks the movement of an electromagnetic capsule through the gastrointestinal tract, allowing calculation of segmental transit times (stomach, small intestine, colon) and total whole-gut transit time. This measure evaluates gastrointestinal motility patterns at baseline. Score range and direction: Transit times are continuous measures reported in minutes or hours. There is no fixed upper or lower limit, as transit times vary physiologically between individuals. Longer transit times indicate slower gastrointestinal motility. Shorter transit times indicate faster gastrointestinal motility. | At baseline |
| Colonic and segmental colonic volumes | Magnetic resonance imaging is used at baseline to quantify total colonic volume and segmental colonic volumes (ascending, transverse, descending, sigmoid/rectum colon). Volumes are derived from semi-automated segmentation of the colon on T2-weighted images. This measure evaluates baseline colonic morphology and storage capacity. Score range and direction: Colonic volumes are continuous measures reported in milliliters (mL). There is no fixed upper or lower limit, as volumes vary physiologically between individuals. Higher values indicate larger colonic or segmental volume. Lower values indicate smaller colonic or segmental volume. | At baseline |
| Resting Anal Pressure Measured by High-Resolution Anorectal Manometry | Resting anal pressure will be measured using high-resolution anorectal manometry according to standard manometric protocols. Resting anal pressure reflects basal anal sphincter tone, primarily related to internal anal sphincter function. The outcome will be reported as a continuous physiological measure in millimeters of mercury (mmHg). There are no fixed minimum or maximum values because pressures vary physiologically between individuals. Higher values indicate higher resting anal sphincter tone, while lower values indicate reduced resting sphincter tone. | At baseline |
| Maximal Voluntary Anal Squeeze Pressure Measured by High-Resolution Anorectal Manometry | Maximal voluntary anal squeeze pressure will be measured using high-resolution anorectal manometry according to standard manometric protocols. Squeeze pressure reflects voluntary external anal sphincter contractile strength. The outcome will be reported as a continuous physiological measure in millimeters of mercury (mmHg). There are no fixed minimum or maximum values because pressures vary physiologically between individuals. Higher values indicate stronger voluntary anal sphincter contraction, while lower values indicate reduced voluntary sphincter contractile function. | At baseline |
| Rear-Front Pressure Gradient Measured by the Fecobionics Device | The rear-front pressure gradient will be measured using the Fecobionics device during simulated stool evacuation. The Fecobionics device records axial pressure patterns during defecation. The rear-front pressure gradient reflects the pressure difference between the rear and front sensors of the device during evacuation and provides a measure of propulsive force relative to outlet resistance. The outcome will be reported as a continuous physiological measure in millimeters of mercury (mmHg). There are no fixed minimum or maximum values because values vary physiologically between individuals. Higher values indicate stronger propulsive pressure relative to outlet resistance, whereas lower values may indicate impaired propulsion or increased outlet resistance. | At baseline |
| Compare the physiological findings in LARS patients with controls | Compare the physioligal findings in LARS patients with a) no-LARS patients, b) organ-preservation patients and c) patient with fecal incontinence | At baseline |
| Investigate the physiological changes in anorectal function associated with neuromodulation in patients with urge fecal incontinence | Changes in anorectal function measured by the Fecobionics Device | From baseline to after 30 minutes of active neuromodulation |
| Investigate the physiological changes in anorectal function associated with neuromodulation in patients with urge fecal incontinence | Changes in anorectal function measured by high-resolution anorectal manometry | From baseline to after 30 minutes of active neuromodulation |
| Investigate the physiological changes in anorectal function associated with neuromodulation in patients with fecal incontinence | Changes in anorectal function measured by the Fecobionics Device | From baseline to after active neuromodulation at Visit 2 |
| Investigate the physiological changes in anorectal function associated with neuromodulation in patients with fecal incontinence | Changes in anorectal function measured by high-resolution anorectal manometry | From baseline to after active neuromodulation at Visit 2 |
| Change in VAS Urgency Score From Before to During Stimulation at the Baseline Visit | The participant's perceived urgency to defecate during the examination will be assessed using a visual analogue scale. Participants with fecal incontinence will rate their urgency to defecate on a numeric scale from 0 to 10, where 0 indicates no desire to defecate and 10 indicates maximal urgency. The outcome will be reported as the change in VAS urgency score from the pre-stimulation assessment to the stimulation assessment at the baseline visit. Higher scores indicate stronger urgency to defecate. | Baseline visit: immediately before stimulation and during active stimulation |
| Resting-State Electroencephalography | Resting-state electroencephalography is recorded with the participant at rest to assess baseline cortical activity patterns. Measures include spectral power across standard frequency bands (theta, alpha, beta). Score range and direction: Spectral power values are continuous and do not have fixed upper limits. Higher or lower values reflect differences in cortical activity depending on frequency band. | At baseline |
| Evoked Potential Amplitude During Rectal Balloon Distension | Electroencephalography is recorded during rapid rectal balloon distension to elicit cortical evoked potentials. The primary measure is the amplitude of the evoked response to visceral stimulation. Score range and direction: Amplitude is measured in microvolts (µV). Higher amplitudes indicate stronger cortical responses to visceral stimulation. | At baseline |
| Evoked Potential Latency During Rectal Balloon Distension | Electroencephalography is recorded during rectal balloon distension to measure the latency of cortical evoked potentials, reflecting the timing of sensory pathway activation. Score range and direction: Latency is measured in milliseconds (ms). Longer latencies indicate slower or delayed cortical processing. Shorter latencies indicate faster neural conduction. | At baseline |
| Defecation Index Measured by the Fecobionics Device | The defecation index will be derived from Fecobionics measurements obtained during simulated stool evacuation. The index summarizes expulsion performance and anorectal function based on prespecified Fecobionics-derived variables. The outcome will be reported as a continuous index value. There are no fixed minimum or maximum values. Higher values indicate more efficient expulsion and better defecatory performance, whereas lower values indicate reduced defecatory performance. | Baseline |
| Recruiting |
| Aarhus |
| 8200 |
| Denmark |
|
| Vejle Hospital | Recruiting | Vejle | 7100 | Denmark |
|
| D012002 | Rectal Diseases |
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012817 | Signs and Symptoms, Digestive |
| D012816 | Signs and Symptoms |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D019960 | Elimination Disorders |
| D001523 | Mental Disorders |